Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Gonda

Neurological Surgery San Diego, CA Medical Doctor

NPI 1427254937 CMS profile 717402

7910 Frost St, Ste 120, San Diego, CA 92123

Open in the dashboard

General payments

$45,786

165 records reported · program years 2019–2025

Research payments

$3,413

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Gonda of San Diego, CA is reported in the CMS Open Payments database as having received $45,786 across 165 general payments and $3,413 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,698 34
2024 General $7,695 17
2023 General $314 7
2023 Research $1,788 2
2022 General $487 8
2022 Research $1,625 2
2021 General $1,892 12
2020 General $3,761 21
2019 General $28,940 66

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Gonda
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to David Gonda were reported at $2,698. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year David Gonda Neurological Surgery median Middle half National median
2019 $28,940 $582 $138–$3,006 $163
2020 $3,761 $294 $76–$2,174 $114
2021 $1,892 $387 $105–$2,432 $132
2022 $487 $542 $139–$2,989 $149
2023 $314 $534 $145–$2,697 $160
2024 $7,695 $574 $155–$3,046 $164
2025 $2,698 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. PTC Therapeutics, Inc. $25,296 9 payments
  2. Medtronic, Inc. $10,406 35 payments
  3. Medtronic USA, Inc. $4,560 30 payments
  4. Monteris Medical Corporation $2,456 10 payments
  5. NeuroPace, Inc. $1,517 23 payments
  6. LivaNova USA, Inc. $258 19 payments
  7. Neurelis, Inc. $200 4 payments
  8. SK Life Science, Inc. $147 1 payment
  9. Jazz Pharmaceuticals Inc. $143 3 payments
  10. DePuy Synthes Sales Inc. $101 5 payments
  11. Other $701 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $17,580 2 payments
  2. Travel and Lodging $16,527 23 payments
  3. Food and Beverage $6,489 134 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,690 5 payments
  5. Honoraria $1,500 1 payment
Products named General payments · program years 2019–2025
  1. VISUALASE MRI-guided laser ablation $10,314 33 payments
  2. VISUALASE MRI-guided laser ablation $4,560 30 payments
  3. Neuroblate $2,456 10 payments
  4. RNS Neurostimulator Kit $740 11 payments
  5. RNS System Epilepsy $504 8 payments
  6. RNS System Epilepsy $274 4 payments
  7. VNS Therapy $258 19 payments
  8. VALTOCO $200 4 payments
  9. Epidiolex $143 3 payments
  10. Shoreline RT $97 1 payment
  11. Other $844 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. PTC Therapeutics, Inc. $3,413 4 payments

Records

169 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record